DOCSLIB.ORG

Nutraceuticals

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Nutraceuticals NIKOLOS PHARMA Nutraceutcals S.NO PRODUCT NAME COMPOSITION STRENGTH INDICATION Each uncoated tablet contains: Antidote. 1. Activated Charcoal Tablets 250 mg Activated Charcoal 250 mg Helps it trap toxins and Excipients q.s chemicals Each uncoated tablet contains: Antidote. Activated Charcoal Tablets 2. Activated Charcoal 500 mg Helps it trap toxins and 500 mg Excipients q.s chemicals Each hard gelatin capsule contains: 3. Avocado Soy Unsaponifiables Capsules Avocado Soy Unsaponifiables 300 mg Joint health supplements Excipients q.s Each film coated tablet contains: 300 mg 4. Avocado Soy Unsaponifiables Tablets Avocado Soy Unsaponifiables q.s Joint health supplements Excipients Each uncoated tablet contains: 150 mg 5. Benfotiamine Tablets 150mg Benfotiamine q.s Dietary supplements Excipients Each capsule contains: Beta Carotene 2.4 mg Beta carotene, Amla, Ashwagandha, Amla Extract 100 mg Menopausal health 6. Chaste berry and Soy Isoflavones capsules Ashwagandha 5% 250 mg & Chaste Berry 100 mg Hormonal balancer Soy Isoflavones 60 mg Excipients q.s NIKOLOS PHARMA PRIVATELIMITED Telephone: +917676764141,ApeejayBusinessCentre,Tresorie,1st Floor,SuiteNo-15,ThePark,22 Raj Bhavan Road, Hyderabad, Telengana - 500082,India E-mail: [email protected], Website: www.nikoIospharma.com NIKOLOS PHARMA S.NO PRODUCT NAME COMPOSITION STRENGTH INDICATION Each film coated tablet contains: Calcium citrate maleate Equivalent to elemental calcium Calcium citrate maleate, Calcitriol and Zinc 250 mg 7. Calcitriol Health supplements Tablets 0.25 mcg Zinc sulphate monohydrate Equivalent to elemental Zinc 7.5 mg Excipients q.s Each film coated tablet contains: Calcium citrate maleate 1000 mg Calcitriol 0.25 mcg Vitamin K2-7 50 mcg Magnesium oxide Calcium, Calcitriol, Multivitamins and 100 mg 8. Boron Health supplements Minerals Tablets 3 mg Manganese Sulphate 5 mg Zinc sulphate monohydrate Equivalent to elemental Zinc 15 mg Mecobalamin 1500 mcg Excipients q.s NIKOLOS PHARMA PRIVATELIMITED Telephone: +917676764141,ApeejayBusinessCentre,Tresorie,1st Floor,SuiteNo-15,ThePark,22 Raj Bhavan Road, Hyderabad, Telengana - 500082,India E-mail: [email protected], Website: www.nikoIospharma.com NIKOLOS PHARMA S.NO PRODUCT NAME COMPOSITION STRENGTH INDICATION Each film coated tablet contains: Calcium citrate maleate 1000 mg Vitamin D3 1000 IU Vitamin K2-7 50 mcg Magnesium oxide Calcium, Vitamin D3, Vitamin K2-7 and Eq. to elemental Magnesium 9. 100 mg Health supplements Minerals Tablets Boron 3 mg Manganese Sulphate Eq. to elemental Manganese 5 mg Zinc sulphate monohydrate Eq. to elemental Zinc 15 mg Excipients q.s Carbamide Forte Probiotics Supplement 30 Each Capsule contains: 10. Billion, 16 Strains with Prebiotics 100 mg Carbamide Forte Probiotics Supplement 30 Billion For healthy Gut Capsules 16 Strains with Prebiotics 100 mg Each capsule contains: Co Enzyme Q 10 100 mg Co enzyme Q 10, L-Arginine and Lycopene 11. L-Arginine 250 mg For healthy Heart Capsules Lycopene 15 mg Excipients q.s Each film coated tablet contains: 12. Co enzyme Q 10 Tablets 300 mg Co enzyme Q 10 For healthy Heart 300 mg Excipients q.s Co enzyme Q 10, L-carnitine and L- Each film coated tablet contains: 13. For healthy Heart Arginine Tablets Co enzyme Q 10 120 mg NIKOLOS PHARMA PRIVATELIMITED Telephone: +917676764141,ApeejayBusinessCentre,Tresorie,1st Floor,SuiteNo-15,ThePark,22 Raj Bhavan Road, Hyderabad, Telengana - 500082,India E-mail: [email protected], Website: www.nikoIospharma.com NIKOLOS PHARMA S.NO PRODUCT NAME COMPOSITION STRENGTH INDICATION L-carnitine L-tartrate 500 mg Choline bitartrate 150mg Selenious acid 200mcg L-Arginine 50mg Excipients q.s Each capsule contains: 125 mg Cordyceps Sinesis 50 mg RubusIdaeus fruit extract Cordyceps Sinesis, RubusIdaeus, Ginseng, 50 mg Ginseng Root Extract For Male fertility Ginkgo Biloba, Wild Yam, Garlic and 60 mg 14. Ginkgo Biloba & Jujube capsules 100 mg Wild Yam Extract Libido functions 50 mg Garlic Extract 50 mg Jujube Extract q.s Excipients Each Capsule contains: Ferrous Fumarate Ferrous Fumarate, Ascorbic Acid and Equivalent to elemental Iron 22.5 mg RBC production / 15. Cyanocobalamin Capsules Ascorbic Acid 20 mg Treats Iron deficiency Cyanocobalamin 0.5 mcg Excipients q.s NIKOLOS PHARMA PRIVATELIMITED Telephone: +917676764141,ApeejayBusinessCentre,Tresorie,1st Floor,SuiteNo-15,ThePark,22 Raj Bhavan Road, Hyderabad, Telengana - 500082,India E-mail: [email protected], Website: www.nikoIospharma.com NIKOLOS PHARMA S.NO PRODUCT NAME COMPOSITION STRENGTH INDICATION Each capsule contains: Garcinia Combogia 60% 250 mg Camellia Sinensis 62.5 mg Green Tea extract 62.5 mg Piperin 95 % 5 mg Garcinia Combogia ,CamelliaSinensis , Vitamin B1 0.7 mg Piperin, Multivitamin and Minerals Vitamin B2 0.8 mg Weight Loss agent / 16. Capsules Vitamin B12 0.5 mcg Fat burner Vitamin C 20 mg Vitamin E 5 mg Calcium D Pantothenate 5 mg Elemental Phosphorus 25 mg Elemental Manganese 2 mg Excipients q.s q.s Each film coated tablet contains: Glucosamine(As Glucosamine Hcl) mg Glucosamine, Chondroitin Sulfate, 500 mg Chondroitin Sulfate Methylsulfonylmethane and Hyaluronic 400 mg Joint health 17. Methyl Sulfonyl Methane acid Tablets 167 mg supplements Hyaluronic Acid 10 mg (As Sodium Hyaluronate) Excipients q.s NIKOLOS PHARMA PRIVATELIMITED Telephone: +917676764141,ApeejayBusinessCentre,Tresorie,1st Floor,SuiteNo-15,ThePark,22 Raj Bhavan Road, Hyderabad, Telengana - 500082,India E-mail: [email protected], Website: www.nikoIospharma.com NIKOLOS PHARMA S.NO PRODUCT NAME COMPOSITION STRENGTH INDICATION Each film coated tablet contains: Glucosamine 750 mg Methylsulfonylmethane 200 mg Glucosamine, Methylsulfonylmethane, Boswellia (Boswellia serrate) extract 200 mg 18. Boswellia extract, Chondroitin Sulfate, Joint health supplements Chondroitin Sulfate 100 mg Curcumin and Hyaluronic acid Tablets Curcumin 50 mg Hyaluronic acid 10 mg Excipients q.s Each hard gelatin capsule contains: Iron (Ferrous Fumarate) 14 mg Iron, Ascorbic acid and Cyanocobalamin RBC production / 19. Vitamin C (Ascorbic acid) 60 mg Capsules Treats Iron deficiency Cyanocobalamin 0.375 mcg Excipients q.s Each film coated tablet contains: Treats endothelial 20. L-5-Methyltetrahydrofolate Tablets L-5-Methyltetrahydrofolate 800 mg dysfunction Excipients q.s Each film coated tablet contains: L-Carnitine L-Tartrate 50 mg Co-enzyme Q 10 50 mg L-Carnitine L-Tartrate, Ginseng 10 mg Co-enzyme Q 10, Ginseng, L-Arginine 10 mg 21. L-Arginine , Lycopene (6%) 5 mg Male infertility Lycopene, L Glutathione with Multivitamin L Glutathione 2.5 mg and Multimineral Tablets Ascorbic acid 40 mg Vitamin E 12.5 mg Pyridoxine Hydrochloride 2 mg Thiamine mononitrate 1.1 mg NIKOLOS PHARMA PRIVATELIMITED Telephone: +917676764141,ApeejayBusinessCentre,Tresorie,1st Floor,SuiteNo-15,ThePark,22 Raj Bhavan Road, Hyderabad, Telengana - 500082,India E-mail: [email protected], Website: www.nikoIospharma.com NIKOLOS PHARMA S.NO PRODUCT NAME COMPOSITION STRENGTH INDICATION Vitamin A 600 mcg Folic acid 200 mcg Zinc sulphate Equivalent to elemental Zinc 7.5 mg Ferrous fumarate Equivalent to elemental Iron 5 mg Manganese chloride Equivalent to elemental Manganese 2 mg Copper sulphate Equivalent to elemental Copper 1 mg Sodium selenate Equivalent to elemental Selenium 100 mcg Excipients q.s Each film coated tablet contains: Coenzyme Q10 100 mg 5000 mcg Lycopene 90 mg Omega-3 fatty acids (Eicosapentaenoic acid) 60 mg Omega-3 fatty acids (Docosahexaenoicacid) 10.33 mg L-Carnitine, Coenzyme Q10, Zinc , Mixed Carotene (10%) 25 Treat CVD & Neurologicalmg 22. Lycopene and Astaxanthin Tablets Wheat Germ oil 75 disorders mg Calcium Ascorbate 5 mcg Vitamin B12 (Cyanocobalamin) 75mcg Selenium (Sodium selenate) 27.45 mg q.s Zinc (Zinc sulphate monohydrate) Excipients Each serving contains: (As two film coated tablets) 23. L-Glutathione and Vitamin C Tablets L-Glutathione 750 mg Healthy skin Vitamin C 1000mg (As Ascorbic acid) NIKOLOS PHARMA PRIVATELIMITED Telephone: +917676764141,ApeejayBusinessCentre,Tresorie,1st Floor,SuiteNo-15,ThePark,22 Raj Bhavan Road, Hyderabad, Telengana - 500082,India E-mail: [email protected], Website: www.nikoIospharma.com NIKOLOS PHARMA S.NO PRODUCT NAME COMPOSITION STRENGTH INDICATION Excipients q.s Each film coated tablet contains: Healthy vascular function & 24. L-Theanine Tablets L-Theanine 100 mg Antianxiety Excipients q.s Each film coated tablet contains: Lycopene (6%) 2000 mcg Vitamin C 25 mg Lycopene, Multivitamin and Minerals Vitamin E 10 mg Anti oxidant / 25. Tablets Vitamin A 600 mcg Nutritional supplements Zinc sulphate 23.45 mg Selenium dioxide 75 mcg Excipients q.s Each film coated tablet contains: Myo-Inositol 550 mg Para Amino Benzoic acid 12.5 mg L-Arginine 10 mg D-Biotin 5 mg Lycopene (6%) 5 mg Ascorbic acid 75 mg Niacinamide 22.5 mg Female infertility / Lycopene, Myo-Inositol, L-Arginine Magnesium Hydroxide 26. Nutritional supplements Multivitamin and Minerals Tablets Equivalent to elemental Magnesium 5 mg during pregnancy Zinc sulphate Equivalent to elemental Zinc 10 mg Ferrous fumarate Equivalent to elemental Iron 9 mg Manganese chloride Equivalent to elemental Manganese 1.5 mg Copper sulphate Equivalent to elemental Copper 750 mcg NIKOLOS PHARMA PRIVATELIMITED Telephone: +917676764141,ApeejayBusinessCentre,Tresorie,1st Floor,SuiteNo-15,ThePark,22 Raj Bhavan Road, Hyderabad, Telengana - 500082,India E-mail: [email protected], Website: www.nikoIospharma.com NIKOLOS PHARMA S.NO PRODUCT NAME COMPOSITION STRENGTH INDICATION Selenium dioxide Equivalent to elemental
Load more

Recommended publications
  • Multi Vitamin Formulations
    Multi Vitamin Formulations The gender-specific men’s and women’s multivitamins and the nerve tissue supplement contain ingredients in a form that the body can easily use, in the recommended daily amounts. These ingredients promote the health of the heart, brain, muscle, bone and other parts of the body by giving them the nutrients they need to function properly. This document goes into what is in each supplement, why those ingredients are present (and in what amounts) and what that particular ingredient does in the body. All ingredients in the supplements are natural and nontoxic, and help support good health. Ingredient review for the Multi Vitamin Supplement The broad-spectrum multivitamins were formulated for men and women according to the current knowledge of daily required amounts of nutrients, and the differences in need (as in iron) between men and women. The polyphenolics, probiotics, and secondary nutrients like carnitine and ubiquinone (CoQ10) were added to help supplement the daily diet, and to help support the tissue-support supplement that it is meant to be taken along with. The focus of this section reviewing the multi-vitamin offering is to understand how these ingredients work in the body to improve overall health, and how the formula compares to the new recommended daily intake values for food and dietary supplements in the updated 21CFR section 101.9 [1]. The ingredient list and dosages for the men’s and women’s multivitamins are described in the table below. Table 1: Overview of the gender specific Multi-Vitamin Ingredient
    [Show full text]
  • B Active™ B Active™
    ÎÇÊ*/Ê >iÀ £ÉÓ»Ê*ÀÌ>LiÊ À`iÀ £{Ê*/ -ÕL i>`}Ê B Active™ 2[X]XRP[0__[XRPcX^]b UÊ-Õ««ÀÌÊi>Ì ÞÊ,iëÃiÊÌÊ-ÌÀiÃÃÊ>`Ê>Ì}Õi UÊ-Õ««ÀÌÊ >ÀL Þ`À>ÌiÊiÌ>LÃÉ*ÃÃLÞÊ,i`ÕViÊ Ã ÎÉ{»Ê À`iÀ UÊ-Õ««ÀÌÊi>Ì ÞÊ iÀÛÕÃÊ-ÞÃÌiÉ`Ài>ÊÉÕiÊÕVÌ £ä*/Ê iÊ*ÕV ià UÊ-Õ««ÀÌÊi>Ì ÞÊÀiÊ >>Vi ÌiÌÊ Ý UÊ-Õ««ÀÌÊ >À`Û>ÃVÕ>ÀÊi>Ì Ê­VÕ`}ÊL`ÊViî Adbb2P]UXT[S<3 UÊ-Õ««ÀÌÊ }ÌÊ>`Êi>Ì ÞÊ` $$&($& B Active™ contains the entire spectrum of B vitamins to support a very wide range of bodily and stress-related functions. It features activated forms of vitamins B2, B6 and B12, with the addition of Benfotiamine, a patented, safe, fat-soluble, more physiologically-active form of thiamin.* BP]cP5T=<'&$& %%0eT]XSP0[STP All 360 Medicine® Formulas Meet or Exceed cGMP quality Standards 3XbRdbbX^] / iÊÜ>ÌiÀÃÕLiÊ ÊÛÌ>ÃÊ >ÛiÊÌÊLiÊ>LÃÀLi`ÊÊÌ iÊÃ>ÊÌiÃÌiÊ>`ÊÌ iÊ}ÊÌÊÌ iÊÛiÀÊÜ iÀiÊ Ì iÞÊ>ÀiÊLÌÀ>ÃvÀi`ÊÌÊÌ iÀÊ>VÌÛiÊViâÞiÊvÀðÊ>ÃÌÀÌiÃÌ>Ê>`ÉÀÊ i«>ÌVÊ«>ÀiÌÊ ÃÊiÞÊÌÊ>vviVÌÊ>LÃÀ«ÌÊ>`ÊÌ iÊ>VÌÛ>ÌÊ«ÀViÃðÊ*>Ã>Ê«ÞÀ`Ý>Êx½Ê« ë >ÌiÊ­*x*®ÊiÛiÃÊÜiÀiÊ vÕ`ÊÌÊLiÊÃ}vV>ÌÞÊÜiÀÊÌ >ÊÀ>ÊÊÓÓÊÕÌÊvÊΣʫ>ÌiÌÃÊÜÌ Ê«>Ài`ÊÛiÀÊvÕVÌ°£ ÊVÌÛiÊVÌ>ÃÊÛÌ>ÃÊ £]Ê Ó]Ê È]Ê>`Ê £ÓÊÊÌ iÀÊ« ÞÃ}V>Þ>VÌÛiÊvÀÊ>}ÊÌ iÊi>ÃiÀÊ ÌÊ >LÃÀLÊ >`Ê ºÀi>`ÞvÀÕÃi»°Ê ÀÊ iÝ>«i]Ê Ê «>ÌiÌÃÊ ÀiViÛ}Ê «ÞÀ`ÝiÊ ]Ê ÞÊ ÎÎÊ «iÀViÌÊ Àië`i`ÊÜÌ Ê>ÊVÀi>ÃiÊÊ«>Ã>Ê*x*ÆÊ ÜiÛiÀ]ÊÌ iÊiÛiÊVÀi>Ãi`ÊÊ>ÊvÊÌ iÊ«>ÌiÌÃÊÀiViÛ}Ê *x*°£ B Active™ *iÀ >«ÃÊ Ì iÊ ÃÌÊ ÌiÀiÃÌ}Ê }Ài`iÌÊ Ê Ì ÃÊ vÀÕ>Ê ÃÊ ivÌ>iÊ ­-LiâÞÌ >i "« ë >Ìi®]Ê>ÊÃ>vi]Êv>ÌÃÕLiÊ>>}ÊvÊÌ >iÊÌ >ÌÊÌÊÞÊÀ>ÃiÃÊL`Ê>`ÊÌÃÃÕiÊiÛiÃÊvÊ Ì >iÊ>ÌÊi>ÃÌÊvÛiÊÌiÃÊ } iÀÊÌ >ÊÌ iÊÜ>ÌiÀÃÕLiÊÃ>Ì]ÊLÕÌÊ>ÃÊÀi>ÃÊL>Û>>LiÊ>vÌiÀÊÌ iÊÀ>Ê >`ÃÌÀ>ÌÊÕ«ÊÌÊΰÈÊÌiÃÊ}iÀÊÌ >ÊÌ >iÊÃ>Ì°ÓÊ
    [Show full text]
  • The Effects of Long-Term Oral Benfotiamine Supplementation On
    Pathophysiology/Complications BRIEF REPORT The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes A 24-month, double-blind, randomized, placebo-controlled trial 1 1 DAVID A. FRASER, PHD KARI ANNE SVEEN, MD RESEARCH DESIGN AND 2 5,6 LIEN M. DIEP, MSC INGEBJØRG SELJEFLOT, PHD d 3 6,7 METHODS The study recruited 67 INGER ANETTE HOVDEN, MD, PHD KRISTIAN F. HANSSEN, MD, PHD 3,4 individuals with type 1 diabetes during KRISTIAN B. NILSEN, MD, PHD routine appointments at the Norwegian Diabetic Centre. Inclusion criteria were 1 2 d ) age 18 to 60 years (inclusive), )type1 OBJECTIVE To study the effects of long-term oral benfotiamine supplementation on pe- diabetes (.15-year duration), and 3) ripheral nerve function and soluble inflammatory markers in patients with type 1 diabetes. normo- or microalbuminuria. All patients RESEARCH DESIGN AND METHODSdThe study randomly assigned 67 patients with provided written informed consent. The type 1 diabetes to receive 24-month benfotiamine (300 mg/day) or placebo supplementation. study, which was approved by the re- Peripheral nerve function and levels of soluble inflammatory variables were assessed at baseline gional ethics committee and the Norwe- and at 24 months. gian Medicines Agency, was conducted RESULTSdFifty-nine patients completed the study. Marked increases in whole-blood con- as a parallel, randomized, double-blind, centrations of thiamine and thiamine diphosphate were found in the benfotiamine group (both placebo-controlled prospective trial of P , 0.001 vs. placebo). However, no significant differences in changes in peripheral nerve 24-month duration.
    [Show full text]
  • Estonian Statistics on Medicines 2016 1/41
    Estonian Statistics on Medicines 2016 ATC code ATC group / Active substance (rout of admin.) Quantity sold Unit DDD Unit DDD/1000/ day A ALIMENTARY TRACT AND METABOLISM 167,8985 A01 STOMATOLOGICAL PREPARATIONS 0,0738 A01A STOMATOLOGICAL PREPARATIONS 0,0738 A01AB Antiinfectives and antiseptics for local oral treatment 0,0738 A01AB09 Miconazole (O) 7088 g 0,2 g 0,0738 A01AB12 Hexetidine (O) 1951200 ml A01AB81 Neomycin+ Benzocaine (dental) 30200 pieces A01AB82 Demeclocycline+ Triamcinolone (dental) 680 g A01AC Corticosteroids for local oral treatment A01AC81 Dexamethasone+ Thymol (dental) 3094 ml A01AD Other agents for local oral treatment A01AD80 Lidocaine+ Cetylpyridinium chloride (gingival) 227150 g A01AD81 Lidocaine+ Cetrimide (O) 30900 g A01AD82 Choline salicylate (O) 864720 pieces A01AD83 Lidocaine+ Chamomille extract (O) 370080 g A01AD90 Lidocaine+ Paraformaldehyde (dental) 405 g A02 DRUGS FOR ACID RELATED DISORDERS 47,1312 A02A ANTACIDS 1,0133 Combinations and complexes of aluminium, calcium and A02AD 1,0133 magnesium compounds A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 811120 pieces 10 pieces 0,1689 A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 3101974 ml 50 ml 0,1292 A02AD83 Calcium carbonate+ Magnesium carbonate (O) 3434232 pieces 10 pieces 0,7152 DRUGS FOR PEPTIC ULCER AND GASTRO- A02B 46,1179 OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 2,3855 A02BA02 Ranitidine (O) 340327,5 g 0,3 g 2,3624 A02BA02 Ranitidine (P) 3318,25 g 0,3 g 0,0230 A02BC Proton pump inhibitors 43,7324 A02BC01 Omeprazole
    [Show full text]
  • Benfotiamine By: Gary E
    Benfotiamine By: Gary E. Foresman, MD 08/30/07 Benfotiamine is a lipid soluble form of thiamine (Vitamin B-1). The great advantage of benfotiamine comes from its lipid soluble state, which improves its absorption (bioavailability), making plasma levels of thiamine rise five times higher than when giving regular thiamine. Clinical trials have shown that despite the improved bioavailability, benfotiamine is significantly less toxic than common thiamine (which has no significant toxicity). This basically means you can’t develop benfotiamine toxicity. There are no drug interactions to be concerned about, and there are no known side-effects to this supplement. Furthermore, anyone taking a diuretic, birth control pills, or tricyclic antidepressants, should consider this supplement, as these drugs deplete B-1 from the body. Regular thiamine (B-1) has such limited bioavailability that many conditions keep our body from absorbing enough B-1 to adequately replete itself. This is where benfotiamine has its clinical utility. Most of the clinical research involved with benfotiamine focuses on its utility in preventing the complications of diabetes. But you could also consider benfotiamine important in anyone with insulin resistance or generally concerned about the aging process. You have heard me mention many times before the damage caused by advanced glycation end products (AGE). Succinctly, AGE’s are formed when blood sugar elevates. Abnormal elevations of blood sugar cause sugar to stick to proteins, causing them to malfunction (AGE). This is the primary cause of diabetic complications, especially in the eyes (retinopathy), kidneys (nephropathy), and nerves (neuropathy). It is also one of the primary causes of aging in general and even in non-diabetics associated with the age related changes involved in high blood pressure, vascular aging and Alzheimer’s.
    [Show full text]
  • Nerve Formula Research
    Nerve Formula Research Effectiveness of Different Benfotiamine Dosage Regimens in the Treatment of Painful Diabetic Neuropathy Winkler G, Pal B, Nagybeganyi E, Ory I, Porochnavec M, Kempler P. 2nd Department of Internal Medicine, Municipal St. John's Hospital, Budapest, Hungary. Arzneimittelforschung. 1999 Mar;49(3):220-4. Abstract The therapeutic effectiveness of a benfotiamine vitamin B combination, administered in high (4 x 2 capsules/day, = 320 mg benfotiamine/day) and medium doses (3 x 1 capsules/day), was compared to a monotherapy with benfotiamine (3 x 1 tablets/day, = 150 mg benfotiamine/day) in diabetic patients suffering from painful peripheral diabetic neuropathy (DNP). In a 6-week open clinical trial, 36 patients (aged 40 to 70 yrs) having acceptable metabolic control (HbA1c < 8.0%) were randomly assigned to three groups, each of them comprising 12 participants. Neuropathy was assessed by five parameters: the pain sensation (evaluated by a modified analogue visual scale), the vibration sensation (measured with a tuning fork using the Riedel-Seyfert method) and the current perception threshold (CPT) on the peroneal nerve at 3 frequencies: 5, 250 and 2000 Hz). Parameters were registered at the beginning of the study and at the end of the 3rd and 6th week of therapy. An overall beneficial therapeutic effect on the neuropathy status was observed in all three groups during the study, and a significant improvement in most of the parameters studied appeared already at the 3rd week of therapy (p < 0.01). The greatest change occurred in the group of patients receiving the high dose of benfotiamine (p < 0.01 and 0.05, resp., compared to the other groups).
    [Show full text]
  • Benfotiaminebenfotiaminebenfotiamine by Gene Bruno, MS, MHS
    SupplementScience BenfotiamineBenfotiamineBenfotiamine By Gene Bruno, MS, MHS enfotiamine is a lipid-soluble form classic deficiency disease “beriberi,” Benfotiamine for Diabetes of thiamine (vitamin B1) often characterized by:5 Benfotiamine has particularly valuable Bconsidered to be the most effec- • Peripheral neuropathy benefits to offer for individuals with dia- tive of the allithiamine group of natural- • Muscle pain and tenderness betes due to its unusual property of ly occurring, thiamine-derived com- • Rapid heart rate inhibiting three major pathways of dia- pounds, found in trace quantities in • Enlargement of the heart betes-induced vascular damage and roasted crushed garlic and other veg- • Edema (severe swelling due to neuropathy, and also having value in etables from the Allium genus (such as water retention) treating diabetic retinopathy and kidney onions, shallots and leeks). It is • Congestive heart failure damage. The three pathways include absorbed much better than water-solu- the hexosamine pathway, the advanced ble thiamine salts: maximum plasma Causes of Thiamine Deficiency glycation end product (AGE) formation levels of thiamine are about five times While thiamine deficiency is not common pathway and the diacylglycerol (DAG)- higher after benfotiamine, the bioavail- in the U.S., there are situations in which a protein kinase C (PKC) pathway.12 AGEs ability is at maximum about 3.6 times as deficiency may result from an increased are particularly nasty, so inhibition of high as that of thiamine hydrochloride requirement or excessive loss of this their formation is especially desirable. and better than other lipophilic thi- nutrient, as well as consumption of anti- amine derivates.1 thiamine factors.
    [Show full text]
  • YMC HPLC Columns Applications Notebook
    WA30000 HPLC Columns Applications Notebook Table of Contents Click on the items below to go directly to that section of the notebook. To Start a new search, click on Table of Contents Bookmark to the left YMC™ HPLC Column Quality Assurance............................................................2 Guide to YMC™ Part Numbering System ...........................................................3 YMC™ Column Selection Guide ....................................................................4-7 HPLC Troubleshooting and Reference Guide..................................................8-14 List of Applications..................................................................................15-20 1. Vitamins .....................................................................................21 2. Carbohydrates ............................................................................32 3. Nucleic Acids .............................................................................43 4. Amino Acids, Peptides, Proteins......................................................48 5. Organic Acids, Fatty Acid Derivatives .............................................60 6. Food Additives ............................................................................62 7. Natural Products ..........................................................................68 8. Steroids......................................................................................77 9. Drugs, Metabolites .......................................................................87
    [Show full text]
  • 197 a Acceptance and Commitment Therapy (ACT) , 75, 76, 78 Acetyl L -Carnitine (ALC) , 91, 129 ACT. See Acceptance and Commitm
    Index A Alpha-lipoic acid (ALA) , 91, 123 Acceptance and commitment therapy Alternative treatments (ACT) , 75, 76, 78 CAM, western society , 84 Acetyl L -carnitine (ALC) , 91, 129 mind-body therapies , 89–91 ACT. See Acceptance and commitment nutraceuticals therapy (ACT) ALA , 91 Acupuncture ALC , 91 alternative medicine techniques , 85 benfotiamine , 91 chemotherapy-induced peripheral fatty acids , 92 neuropathy , 89 vitamin B12 de fi ciency , 92 Chinese medicine , 84 zinc , 92 description , 66 osteopathic medicine , 83 DPN patients , 187–188 stimulation-based therapies moxibustion , 86 ( see Acupuncture) multicenter randomized controlled traditional medicine , 83 trial , 88–89 American Diabetes Association (ADA) , needles , 86 194–195 opioid receptors and endorphins , 85 Amyotrophy serotonin receptors , 85 asymmetrical proximal leg side effects , 88 weakness , 162 TCM , 86, 88 DPN , 162 timeline , 86, 87 ESR , 162 Acute painful neuropathy MRI, CT/ultrasound , 162 poor glycaemic control , 157 pain , 162 rapid glycaemic control (insulin neuritis) , type 1 and type 2 diabetic patients , 162 157–158 Anticonvulsants, DPN transient neuropathic syndromes , 157 adverse event related withdrawal , Advanced practice registered nurses 178–179 (APRNs) , 142 effects, quality of life and physical ALA. See Alpha-lipoic acid (ALA) functioning , 178 ALC. See Acetyl L -carnitine (ALC) ef fi cacy, individual , 178 Aldose reductase inhibitors (ARI) , 128 epilepsy , 177 Allodynia , 17–19 impacts , 179 Alpha-2-delta ligand agonist antiepileptic inhibition ,
    [Show full text]
  • Estonian Statistics on Medicines 2013 1/44
    Estonian Statistics on Medicines 2013 DDD/1000/ ATC code ATC group / INN (rout of admin.) Quantity sold Unit DDD Unit day A ALIMENTARY TRACT AND METABOLISM 146,8152 A01 STOMATOLOGICAL PREPARATIONS 0,0760 A01A STOMATOLOGICAL PREPARATIONS 0,0760 A01AB Antiinfectives and antiseptics for local oral treatment 0,0760 A01AB09 Miconazole(O) 7139,2 g 0,2 g 0,0760 A01AB12 Hexetidine(O) 1541120 ml A01AB81 Neomycin+Benzocaine(C) 23900 pieces A01AC Corticosteroids for local oral treatment A01AC81 Dexamethasone+Thymol(dental) 2639 ml A01AD Other agents for local oral treatment A01AD80 Lidocaine+Cetylpyridinium chloride(gingival) 179340 g A01AD81 Lidocaine+Cetrimide(O) 23565 g A01AD82 Choline salicylate(O) 824240 pieces A01AD83 Lidocaine+Chamomille extract(O) 317140 g A01AD86 Lidocaine+Eugenol(gingival) 1128 g A02 DRUGS FOR ACID RELATED DISORDERS 35,6598 A02A ANTACIDS 0,9596 Combinations and complexes of aluminium, calcium and A02AD 0,9596 magnesium compounds A02AD81 Aluminium hydroxide+Magnesium hydroxide(O) 591680 pieces 10 pieces 0,1261 A02AD81 Aluminium hydroxide+Magnesium hydroxide(O) 1998558 ml 50 ml 0,0852 A02AD82 Aluminium aminoacetate+Magnesium oxide(O) 463540 pieces 10 pieces 0,0988 A02AD83 Calcium carbonate+Magnesium carbonate(O) 3049560 pieces 10 pieces 0,6497 A02AF Antacids with antiflatulents Aluminium hydroxide+Magnesium A02AF80 1000790 ml hydroxide+Simeticone(O) DRUGS FOR PEPTIC ULCER AND GASTRO- A02B 34,7001 OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 3,5364 A02BA02 Ranitidine(O) 494352,3 g 0,3 g 3,5106 A02BA02 Ranitidine(P)
    [Show full text]
  • Pathophysiology of Diabetic Peripheral Neuropathy 1
    DR DR DR METABOLIC SOLUTIONS FOR VASCULAR AND MEDICAL FOODS | EB-N3 EB-N5 EB-N6 NEUROPATHIC CONDITIONS Therapeutic Active Pharmaceutical Ingredient Guide EB-N3 DR EB-N5 DR EB-N6 DR ACTIVE INGREDIENT DESCRIPTION / / Nitric oxide and nerve blood flow L-methylfolate calcium [active folate (pure crystalline)] + Delayed Release – Homocysteine levels Peripheral nerve protein synthesis Methylcobalamin [active vitamin B ] + PATHOLOGY OF 12 – Homocysteine levels Advanced glycation end products PERIPHERAL NEUROPATHY Pyridoxal 5'-phosphate [active vitamin B ] – 6 – Homocysteine levels Peripheral nerve blood flow The active pharmaceutical grade Alpha-lipoic acid [antioxidant] + – Oxidative stress ingredients work synergistically to help Cholecalciferol [active vitamin D ] Nerve growth factor normalize and optimize metabolic 3 + factors involved in peripheral nerve and Benfotiamine [active vitamin B 1] – Advanced glycation end products vascular health. Riboflavin [active vitamin B 2] – Homocysteine levels PROPOSED PATHOPHYSIOLOGY OF DIABETIC PERIPHERAL NEUROPATHY 1 Causes are thought to be a multifactorial metabolic process that deteriorates vascular and neuronal tissues. EB-N3 DR EB-N5 DR EB-N6 DR * * * mia Neur Delayed Release Delayed Release Delayed Release che onal l Is De P5P na Redu my L-Methylfolate ro ced eli Benfotiamine eu N na Alpha-lipoic acid N er ti Alpha-lipoic acid L-methylfolate calcium ........6 mg L-methylfolate calcium ........6 mg L-methylfolate calcium ........ 6 mg n/ ve on io G /O Cholicalciferol t ro x c w i Methylcobalamin ..................4 mg Methylcobalamin ..................4 mg Methylcobalamin .................. 4 mg ri d t th a s t n F iv Pyridoxal 5'-phosphate .... 70 mg Pyridoxal 5'-phosphate .....70 mg Pyridoxal 5'-phosphate .....70 mg o Advanced a e c c t S o o t s r r Microvascular Glycation e Riboflavin .................................
    [Show full text]
  • Product Monograph Myelogen
    PRODUCT MONOGRAPH MYELOGEN FORTE NU (Methylcobalamin 1500 mcg + Benfotiamine 100 mg + Alpha Lipoic Acid 100 mg + Folic acid 1.5 mg + Pyridoxine Hydrochloride 3mg) For Diabetic Peripheral Neuropathy Manufactured By: Date of Preparation: Panacea Biotec Limited. (04 June 2019) (Address as on Package) 1 Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION Page No. SUMMARY PRODUCT INFORMATION 3 INDICATIONS AND CLINICAL USE 4 CONTRAINDICATIONS 4 WARNINGS AND PRECAUTIONS 4 ADVERSE REACTIONS 7 DRUG INTERACTIONS 11 DOSAGE AND ADMINISTRATION 13 OVERDOSAGE 13 ACTION AND CLINICAL PHARMACOLOGY 14 STORAGE AND STABILITY 17 SPECIAL HANDLING INSTRUCTIONS 17 DOSAGE FORMS, COMPOSITION AND PACKAGING 17 PART II: SCIENTIFIC INFORMATION 18 PHARMACEUTICAL INFORMATION 18 CLINICAL TRIALS NA TOXICOLOGY NA REFERENCES 22 PART III: CONSUMER INFORMATION 23 2 MYELOGEN FORTE NU (Methylcobalamin 1500 mcg + Benfotiamine 100 mg + Alpha Lipoic Acid 100 mg + Folic acid 1.5 mg + Pyridoxine Hydrochloride 3mg) For Diabetic Peripheral Neuropathy PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION Route of Dosage Form / Approved Indications Administration Strength Oral One Capsule of MYELOGEN Diabetic Peripheral FORTE NU Neuropathy in Adults. contains Methylcobalamin 1500 mcg + Benfotiamine 100 mg + Alpha Lipoic Acid 100 mg + Folic acid 1.5 mg + Pyridoxine Hydrochloride 3mg 3 INDICATIONS AND CLINICAL USE Diabetic Peripheral Neuropathy in adults developed as a late manifestation of uncontrolled or long-standing diabetes that are treated with more than one antidiabetic drugs and significantly affects quality of life. CONTRAINDICATIONS Hypersensitivity to any of the components of formulation. WARNINGS AND PRECAUTIONS Methylcobalamin: Vitamin B12 should, if possible, not be given to patients with suspected vitamin B12 deficiency without first confirming the diagnosis.
    [Show full text]